Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV Dementia.

Avindra Nath1, Joseph Berger

  • 1Department of Neurology, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA. anath1@jhmi.edu

Current Treatment Options in Neurology
|February 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurological Manifestations in Adult Survivors of Ebola Virus Disease.

JAMA neurology·2026
Same author

The next phase in Long COVID research: addressing the ethical challenges in trials of disease-modifying treatments.

EClinicalMedicine·2026
Same author

Functional Activity of TDP-43: A Direct Biomarker for ALS.

medRxiv : the preprint server for health sciences·2026
Same author

Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses.

Brain : a journal of neurology·2026
Same author

Genetic mechanisms underlying host susceptibility to central nervous system viral infections.

Current opinion in infectious diseases·2026
Same author

Downregulation of miRNAs Accompanies Increased HERV-K (HML-2) Expression in Amyotrophic Lateral Sclerosis.

Molecular neurobiology·2026
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Early detection and treatment of HIV-related cognitive impairment are crucial for stabilization and symptom reversal. Individualized antiretroviral therapy, considering drug penetration and resistance, is key for managing HIV dementia.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pharmacology

Background:

  • HIV infection can lead to dementia and cognitive impairment with significant socioeconomic impact.
  • Early detection and prompt, aggressive treatment are vital for managing these neurological manifestations.
  • Some patients may experience symptom reversal with effective antiretroviral therapy.

Purpose of the Study:

  • To outline essential strategies for managing HIV-associated cognitive impairment.
  • To emphasize the importance of individualized antiretroviral treatment regimens.
  • To discuss the role of combination antiretroviral therapy and drug selection criteria.

Main Methods:

  • Review of current therapeutic approaches for HIV-related cognitive impairment.
  • Consideration of factors influencing antiretroviral drug selection, including CNS penetration and resistance.

Related Experiment Videos

  • Discussion of treatment goals, such as viral load control in CNS and periphery.

    • Main Results:

    • Combination antiretroviral therapy is the preferred approach.
    • Specific antiretroviral drugs like zidovudine, stavudine, abacavir, nevirapine, and indinavir show good CNS penetration.
    • Effective therapy can lead to stabilization and potential reversal of cognitive symptoms.

    Conclusions:

    • Individualized antiretroviral therapy, prioritizing CNS penetration and viral load control, is essential.
    • A multidisciplinary approach with regular follow-up is crucial for optimal management.
    • Neuroprotective agents and anti-inflammatory regimens may be considered as adjunctive therapies.